<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Diabetes]]></title>
    <link>https://www.leadingmarketresearch.com/medical-devices-in-vitro-diagnostics/medical-devices/diabetes</link>
    <description><![CDATA[Diabetes]]></description>
    <pubDate>Fri, 17 Apr 2026 20:34:00 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Diabetes - Pipeline Insight, 2024]]></title>
      <link>https://www.leadingmarketresearch.com/diabetes-pipeline-insight-2024</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">“Diabetes – Pipeline Insight, 2024,” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Geography Covered
Global coverage
Diabetes Understanding

Diabetes: Overview

Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin or alternatively, when the body cannot effectively use the insulin it produces. The vast majority of Diabetes can be classified as either type 1 or type 2 diabetes. Type 1 diabetes is an autoimmune disease is characterized by a lack of insulin production by the pancreas. Type 2 diabetes occurs when body becomes resistant to insulin, and sugar builds up in the blood. About 90% of people with diabetes around the world have type 2. It is largely the result of excess body weight and physical inactivit...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-230356"><span class="price">$5,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 28 Oct 2024 19:12:19 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Insulin Delivery Pen Market Size, Growth, Trends, Share and Forecast 2024 – 2032]]></title>
      <link>https://www.leadingmarketresearch.com/global-diabetes-insulin-delivery-pen-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">The global diabetes insulin delivery pen market size was valued at USD 17.7 Billion in 2023 and is likely to reach USD 28.7 Billion in 2032, expanding at a CAGR 5.5% during the forecast period.

The most important factors expected to contribute to the growth of the global diabetes insulin delivery pen market:

Growing Prevalence of Diabetes
Preference for Convenient and User-Friendly Devices
Technological Advancements
Increased Focus on Customization and Personalization
Rising Awareness and Education
Integration with Continuous Glucose Monitoring (CGM) Systems

“Global Insulin Delivery Pen Market Size, Growth, Trends, Share and Forecast 2024 – 2032” presents an in-depth assessment of the global insulin delivery pen market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the global insulin delivery pen market. The report also provides up-to-date historical market size data for the period 2018 – 2023 and an illustrative f...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225539"><span class="price">$3,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 23 May 2022 12:18:53 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/diabetic-neuropathy-drugs-in-development-by-stages-target-moa-roa-molec</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy - Drugs In Development, 2022, provides an overview of the Diabetic Neuropathy (Metabolic Disorders) pipeline landscape.<br><br>Diabetic neuropathy, a common complication of diabetes, is damage to the nerves that allow feeling things such as pain. Symptoms include tingling, numbness, burning and pain. The predisposing factors are obesity, hypertension, high lipid and sugar levels, smoking, etc. It may be managed by medication and dietary modification. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Diabetic Neuropathy - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Diabetic Neuropathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228282"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 26 Dec 2022 14:24:58 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/diabetic-retinopathy-drugs-in-development-by-stages-target-moa-roa-mole</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Drugs In Development, 2022, provides an overview of the Diabetic Retinopathy (Metabolic Disorders) pipeline landscape.<br><br>Diabetic retinopathy is a complication of diabetes that affects the eyes. Diabetic retinopathy symptoms may include spots or dark strings floating in vision (floaters), blurred vision, fluctuating vision, vision loss and difficulty with color perception. The predisposing factors include diabetes, high blood pressure, high cholesterol, pregnancy and tobacco use. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Diabetic Retinopathy - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Diabetic Retinopathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological a...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228283"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 26 Dec 2022 14:24:58 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/type-1-diabetes-juvenile-diabetes-drugs-in-development-by-stages-target</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) - Drugs In Development, 2022, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline landscape.<br><br>Type 1 diabetes (T1D) is an autoimmune disease in which a pancreas stops producing insulin, a hormone that enables people to get energy from food. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. Risk factors of type 1 diabetes include genetics and family history, diseases of the pancreas and infection or illness. The signs and symptoms of type 1 diabetes include increased thirst and frequent urination, extreme hunger, weight loss, fatigue, irritability or unusual behavior. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Type 1 Diabetes (Juvenile Diabetes) - Drugs In Development, 2022, provides comprehensive information on the therapeutics under developme...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228284"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 26 Dec 2022 14:24:58 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/type-2-diabetes-drugs-in-development-by-stages-target-moa-roa-molecule</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Drugs In Development, 2022, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.<br><br>Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a characteristic feature. The body might become resistant to insulin or may not produce enough amounts. Due to abnormal insulin functioning, glucose is concentrated in the blood leading to elevated levels and hence causing type 2 diabetes. Symptoms include fatigue, weight issues, vision deficits and various other effects. Risk factors include family history, age, obesity, physical inactivity and high blood pressure. This condition is handled by lifestyle alterations and regular medications. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Type 2 Diabetes - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Type 2 ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228285"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 26 Dec 2022 14:24:58 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetic Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/diabetic-gastroparesis-drugs-in-development-by-stages-target-moa-roa-mo</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Drugs In Development, 2022, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape.<br><br>Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts of the body, including the vagus nerve, which controls contractions of the stomach during digestion. Spasms, abdominal pain, feelings of fullness after a small amount of food, and other symptoms such as nausea and vomiting, reflux, heartburn, and bloating are often experienced with gastroparesis. Loss of appetite and reduced absorption of nutrients may also be experienced. Gastroparesis can lead to weight loss and malnutrition. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Diabetic Gastroparesis - Drugs In Development, 2022, provides comprehensive information on the therapeutics under develop...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226164"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 13:17:15 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetic Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/diabetic-nephropathy-drugs-in-development-by-stages-target-moa-roa-mole</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Drugs In Development, 2022, provides an overview of the Diabetic Nephropathy (Metabolic Disorders) pipeline landscape.<br><br>Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by albuminuria, reduction in glomerular filtration rate and high blood pressure. Risk factors include obesity, hypertension, high lipid and sugar levels and smoking. This condition is managed by medication and dietary modification. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Diabetic Nephropathy - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Diabetic Nephropathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its compl...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226181"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 13:17:15 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Diabetes Care Devices Market]]></title>
      <link>https://www.leadingmarketresearch.com/global-diabetes-care-devices-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">ResearchCubes Diabetes Care Devices Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the  critical & timely requirement of business information of medical devices business leaders.
The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost.


•    What is the current Diabetes Care Devices Market size and future potential?  
•    What is the geographical segmentation of the Diabetes Care Devices Market? 
•    What are the emerging pipeline products available in the Diabetes Care Devices Market?
•    What are the various products currently under development/pipeline in the Diabetes Care Devices Market, by category, by product type, by company and by d...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225873"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 10:32:26 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[United States Diabetes Insulin Delivery Pen Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026]]></title>
      <link>https://www.leadingmarketresearch.com/united-states-diabetes-insulin-delivery-pen-market-companies-profiles-siz</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">The United States insulin delivery pen market is anticipated to reach US$ 5 billion by 2026, witnessing an impressive double-digit growth rate in the forecast period 2019 – 2026.

“United States Diabetes Insulin Delivery Pen Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026” presents an in-depth assessment of the United States insulin delivery pen market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the United States insulin delivery pen market. The report includes historical data from 2013 to 2018 and forecasts until 2026.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin delivery pen and its segment smart, reusable and disposable insulin pen and illustrative forecast to 2026. A comprehensive analysis has been done on the market share of insulin delivery pen users and market size. The report provide...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225519"><span class="price">$1,290.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 23 May 2022 12:18:53 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Worldwide Diabetes Disposable Insulin Delivery Pen Market Prospect, Share, Development, Growth &amp; Demand Forecast to 2026]]></title>
      <link>https://www.leadingmarketresearch.com/worldwide-diabetes-disposable-insulin-delivery-pen-market-prospect-share</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Worldwide Diabetes Disposable Insulin Delivery Pen Market size is anticipated to exceed USD 14 billion by 2026.

The objective of this market research report is to provide a comprehensive analysis of the fast-evolving, high-growth worldwide diabetes disposable insulin delivery pen market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the worldwide diabetes disposable insulin delivery pen market. The report provides historical market data for 2013 – 2019, and forecasts from 2020 till 2026.

Report Scope:

• To Analyze and Forecast the Market Size of the Worldwide Diabetes Disposable Insulin Delivery Pen
• To Analyze and Forecast the Market Size of the Nationwide Diabetes Disposable Insulin Delivery Pen with Six Years Forecast
• To Classify and Forecast the Worldwide Diabetes Disposable Insulin Delivery Pen Users 
• Detailed Assessment of the Nationwide Diabetes Disposable Insulin Delivery Pen Users
• Detailed Market Share Assessment of the Worldwide Diabetes Disposable Insulin Delivery Pen Market
• Detailed Asse...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225545"><span class="price">$1,699.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 23 May 2022 12:18:53 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Worldwide Diabetes Reusable Insulin Delivery Pen Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2026]]></title>
      <link>https://www.leadingmarketresearch.com/worldwide-diabetes-reusable-insulin-delivery-pen-market-demand-insights</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Worldwide Diabetes Reusable Insulin Delivery Pen Market size is expected to touch US$ 6 billion by 2026.

The following factors are likely to contribute to the growth of the diabetes reusable insulin delivery pen market during the forecast period:

• Rising Population of Diabetes Patients
• High Rate of Adoption
• Increasing Demand for Human Insulin Analogue
• Increasing Popularity of Reusable Insulin Pen Among Consumers

“Worldwide Diabetes Reusable Insulin Delivery Pen Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2026” is based on comprehensive research of the worldwide diabetes reusable insulin delivery pen market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the worldwide diabetes reusable insulin delivery pen market. The report provides historical market data for 2013 – 2019, and forecasts from 2020 until 2026. 

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, reusable insulin pen vo...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-225546"><span class="price">$1,699.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 23 May 2022 12:18:53 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Diabetes Test Market Research Report 2022-2026]]></title>
      <link>https://www.leadingmarketresearch.com/global-diabetes-test-market-research-report-2022-2026</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Diabetes Test Report by Material, Application, and Geography – Global Forecast to 2026 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Diabetes Test market is valued at USD XX million in 2022 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2022 to 2026.

The report firstly introduced the Diabetes Test basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the repor...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-224712"><span class="price">$3,200.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Apr 2022 14:34:41 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Diabetic Pen Cap Market Research Report 2022-2026]]></title>
      <link>https://www.leadingmarketresearch.com/global-diabetic-pen-cap-market-research-report-2022-2026</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Diabetic Pen Cap Report by Material, Application, and Geography – Global Forecast to 2026 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Diabetic Pen Cap market is valued at USD XX million in 2022 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2022 to 2026.

The report firstly introduced the Diabetic Pen Cap basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-224499"><span class="price">$3,200.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Apr 2022 13:06:51 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetes Drugs Markets in China]]></title>
      <link>https://www.leadingmarketresearch.com/diabetes-drugs-markets-in-china</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">China&#039;s demand for   Diabetes Drugs   has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China&#039;s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2010, 2015 and 2020) and long-term forecasts through 2025 and 2030 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conduc...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-218516"><span class="price">$4,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 12 May 2021 15:00:05 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetes Drugs Industry Forecasts - China Focus]]></title>
      <link>https://www.leadingmarketresearch.com/diabetes-drugs-industry-forecasts-china-focus</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This study focuses on China’s Diabetes Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace.   The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services.  The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market. 

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-218567"><span class="price">$1,800.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 12 May 2021 15:00:05 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetes Drugs Companies in China]]></title>
      <link>https://www.leadingmarketresearch.com/diabetes-drugs-companies-in-china</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This study focuses on China’s Diabetes Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace.   The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services.  The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market. 

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering f...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-218618"><span class="price">$1,800.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 12 May 2021 15:00:05 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetes Pen Market Market Insights, Competitive Landscape and Market Forecast–2025]]></title>
      <link>https://www.leadingmarketresearch.com/diabetes-pen-market-market-insights-competitive-landscape-and-market-forec</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s ‘Diabetes Pen Market-Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Diabetes Pen Market and the historical and forecasted Diabetes Pen Market market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Diabetes Pen Market market report provides an overview of Diabetes Pen Market, reasons to get Diabetes Pen Market as well as its advantages and limitations. Additionally, the report provides insight on the Diabetes Pen Market market share of the individual Diabetes Pen Market devices, current and forecasted Diabetes Pen Market market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Diabetes Pen Market Overview
A diabetes pen ensures delivery of insulin in the patient&#039;s body in patients suffering from diabeters. The pen is composed of a catridge that carries insulin hormone, a dial to mea...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-217537"><span class="price">$4,750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 05 Feb 2021 15:36:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Dementia with Diabetes – Pipeline Insight, 2020]]></title>
      <link>https://www.leadingmarketresearch.com/dementia-with-diabetes-pipeline-insight-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s, “Dementia with Diabetes – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Dementia with Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Geography Covered
• Global coverage
Dementia with Diabetes Understanding
Dementia with Diabetes: Overview
Diabetes can cause several complications, such as damage to blood vessels. Diabetes is considered a risk factor for vascular dementia. This type of dementia occurs due to brain damage that is often caused by reduced or blocked blood flow to brain. Many people with diabetes have brain changes that are hallmarks of both Alzheimer&#039;s disease and vascular dementia. Some researchers think that each condition fuels the damage caused by the other.
There&#039;s a lot of research suggesting a connection between diabetes an...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-215959"><span class="price">$1,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Oct 2020 14:02:56 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Insulin Pens (Diabetes Care Devices) - Global Market Analysis and Forecast Model]]></title>
      <link>https://www.leadingmarketresearch.com/insulin-pens-diabetes-care-devices-global-market-analysis-and-forecast</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Insulin Pens (Diabetes Care Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area.<br><br>Diabetes mellitus is a worldwide epidemic disease. Globally, diabetes prevalence is estimated to be 9.3% in 2019 and will rise to 10.2% by 2030. People with insulin-dependent diabetes require intensive insulin therapy to manage their blood glucose levels. To keep glucose level on check, insulin shots are given externally at regular intervals. Insulin can be delivered by syringes, insulin pumps, and insulin pens. Insulin pens dominates the global insulin delivery market due to their easy usage, increased patient satisfaction, and cost-effectiveness. The adoption trend is expected to continue in the forecast period due to the growing prevalence of diabetes globally, development in technologies, and increased demand in developing countries. Devices considered in this market include - <br>- Disposable insulin pens<br>- Reusable insulin pens<br><br>Each of the covered 39 country’s ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-213730"><span class="price">$7,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 24 Feb 2020 15:56:48 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2019]]></title>
      <link>https://www.leadingmarketresearch.com/proliferative-diabetic-retinopathy-pdr-pipeline-review-h2-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2019, provides an overview of the Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline landscape.<br><br>Proliferative diabetic retinopathy (PDR) is the most severe type of diabetic retinopathy. Proliferative diabetic retinopathy occurs where fragile new blood vessels form on the surface of the retina over time. These abnormal vessels can bleed or develop scar tissue causing severe loss of sight. Predisposing factors include diabetes, high blood pressure, high cholesterol, pregnancy and tobacco use. Symptoms include spots or dark strings floating in vision, vision loss, fluctuating vision, blurred vision and difficulty with color perception. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under developmen...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212728"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Dec 2019 11:38:48 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetic Nephropathy - Pipeline Review, H2 2019]]></title>
      <link>https://www.leadingmarketresearch.com/diabetic-nephropathy-pipeline-review-h2-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Pipeline Review, H2 2019, provides an overview of the Diabetic Nephropathy (Metabolic Disorders) pipeline landscape.<br><br>Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by albuminuria, reduction in glomerular filtration rate and high blood pressure. Risk factors include obesity, hypertension, high lipid and sugar levels and smoking. This condition is managed by medication and dietary modification. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Diabetic Nephropathy - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Diabetic Nephropathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212623"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Dec 2019 11:13:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetes Market Analysis, Size, Trends | Europe | 2019-2025 | MedSuite]]></title>
      <link>https://www.leadingmarketresearch.com/diabetes-market-analysis-size-trends-europe-2019-2025-medsuite</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212259"><span class="price">$13,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Nov 2019 13:39:22 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Diabetic Foot   Market Insights, Epidemiology and Market Forecast- 2028]]></title>
      <link>https://www.leadingmarketresearch.com/diabetic-foot-market-insights-epidemiology-and-market-forecast-2028</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight&#039;s “Diabetic Foot - Market Insights, Epidemiology and Market Forecast – 2028” report provides  the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2017-2028.

Markets Covered

• United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2017-2028

Diabetic Foot Understanding and Treatment Algorithm

The report provides the in depth analysis of the disease overview by providing details such as disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The comprehensive details about treatment algorithms and treatment guidelines for Diabetic Foot in the US, Europe, and Japan are also provided in the report.

Diabetic Foot Epidemiology

This section provide the insights about historical and curr...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-211901"><span class="price">$6,250.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 13 Nov 2019 11:03:24 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Diabetes Drugs Market Research Report 2019-2023]]></title>
      <link>https://www.leadingmarketresearch.com/global-diabetes-drugs-market-research-report-2019-2023</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Diabetes Drugs Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Diabetes Drugs market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023.

The report firstly introduced the Diabetes Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the re...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-211279"><span class="price">$2,850.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 11 Nov 2019 13:49:04 +0000</pubDate>
    </item>
  </channel>
</rss>
